ArticlePatient preference and adherence2026
Bidirectional Longitudinal Associations Among Health-Related Quality of Life, Emotional Expressivity, and Readiness to Return to Work in Patients with Non-Muscle-Invasive Bladder Cancer Receiving Intravesical Therapy: A Three-Wave Cohort Study.
Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We aimed to elucidate the temporal relationship among health-related quality of life(HRQoL), emotional expressivity, and readiness for return to work(RRTW) in patients with non-muscle-invasive bladder cancer receiving intravesical therapy. Design: A three-wave cohort study. Methods: In this prospective observational study, we recruited 425 patients from two tertiary hospitals between August 2022 and January 2024. Three waves of self-reported questionnaires were administered at the start of at the start of intravesical therapy (T1, N=412), at six months (T2, N=309), and at twelve months (T3, N=227). The main analysis was based on data from patients who completed all three waves of the assessment. We constructed cross-lagged panel models to examine the temporal associations among HRQoL, emotional expressivity, and RRTW. Results: A total of 227 patients completed all three waves of assessment. Controlling for covariates such as intravesical therapy medication, age, gender, economic income, and marital status, the results indicated a longitudinal relationship between HRQoL at T1 and T2 and emotional expressivity and RRTW at T2 and T3. Emotional expressivity at T1 and T2 was positively associated with HRQoL and RRTW at T2 and T3. HRQoL and emotional expressivity were mutually reinforcing relationships. RRTW at T1 and T2 was positively associated with HRQoL at T2 and T3; however, this positive association disappeared after emotional expressivity was added. Mediation analyses revealed that HRQoL at T1 was positively associated with RRTW at T3 through emotional expressivity at T2 (standardized indirect effect=0.020, 95% bootstrap CI [0.005, 0.035]). Conclusion: These results demonstrated that HRQoL and emotional expressivity mutually reinforced effect relationships, and both could facilitate RRTW among non-muscle-invasive bladder cancer receiving intravesical therapy. As an observational study, these findings identify potential targets for intervention but require confirmation in experimental designs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.